Bob Munro retweeted
Here is a blog I wrote about why I feel MRD negativity should be used as a surrogate endpoint in #myeloma clinical trials. MRD as a Clinical Trial Endpoint: A Patient Perspective healthtree.org/myeloma/commu… #MMSM
Bob Munro retweeted
Summary of drug approvals in relapsed myeloma. 19 new drugs approved over 20 years.
Bookmark it! #MedTwitter
Bob Munro retweeted
‘Shaping the Future of Cancer Care', Bob Munro @MyeCyclist, @MyelomaUK patient advocate discusses his myeloma journey and Dr Ross Sadler covers the importance of primary care providers.
Available, 9am on #WorldCancerDay, Sunday 4th February: business.itn.co.uk/programme… #cancercare
Bob Munro retweeted
Please retweet and help us reach over 1000 respondents so we can get a representation of everyone's experiences. If you are/have been affected by myeloma/related conditions (e.g MGUS, smouldering myeloma) we want to hear from you! Survey 2 closes at midnight on Sunday.
🧵1/4 Thank you to all of the amazing patients and carers who have taken part in Survey 2 of our Unmet and Emerging Needs research so far.
There's still time to take the survey and share your experiences with us: opinions.research-interactiv…
Bob Munro retweeted
Only a week until our Unmet and Emerging Needs Survey closes! If you can, please fill it in and tell us more about your experiences. Please also reshare to help us reach as many people as possible. 🧡
We were delighted by the response to our first Unmet and Emerging Needs Survey, with over 1,000 of you taking part! Please fill in our final Unmet and Emerging Needs Survey and tell us more about your experiences: opinions.research-interactiv…
Bob Munro retweeted
Cancer continues to threaten millions of lives
But to witness a stage IV patient enter remission, having received not a drop of chemotherapy but rather immunotherapy, is a near-miracle I didn’t foresee when my career began
Not all tears in an oncology clinic are shed in sadness
Bob Munro retweeted
🧵 1/3 We're delighted to announce the appointment of Professor Graham Jackson as Myeloma UK's first Chief Clinical and Scientific Advisor! @profghjackson
myeloma.org.uk/news/myeloma-…
Bob Munro retweeted
Real world data from Canada for transplant eligible patients with myeloma shows median overall survival of 10 years:
13 years for std risk
7.5 years for high risk.
This is real progress. #ASH22 #JulieCote @HiraSMian ash.confex.com/ash/2022/webp…
Bob Munro retweeted
Great to hear results showing performance and potential of BiSpecifics - #HopefulFuture room filled ... overflow rooms needed to accommodate delegates! #ASH22 #Myeloma @MyelomaUK
Bob Munro retweeted
Replying to @DrEmmaSearle
@DrEmmaSearle presenting exciting data from the TEC-2 study. TEC/Dara/Len combination. Impressive >=VGPR rate of 90% #ASH22 #mmsm
Bob Munro retweeted
Myeloma Clinical Olympics on the potential of new treatments (Bi- Specifics and T-cells) to deliver better outcomes for relapsed and refractory patients. #ASH22 @MyelomaUK
Bob Munro retweeted
ASH 2021: Iceland — Value of Screening and Early Treatment Comes Into Focus #mmsm #myeloma #ASH21 #HealthTreeMM #AMLsm #HealthTreeAML myelomacrowd.org/ash-2021-ic…
Bob Munro retweeted
Get vaccinated !!! There is no conspiracy and these vaccines are a medical and scientific triumph
This Post is from a suspended account. Learn more
Bob Munro retweeted
Next time you find a cyclist irritating, please remember Marta, who died on the road I take to work.
@StopKillingCycl @willnorman @AndyCoxDCS @JKBartsHeart @betterstreetskc @HounslowCycling @jonsnowC4 @thehistoryguy @Chris_Boardman @chrishoy @LauraKenny31 @rjdekanter
Bob Munro retweeted
Inspiringly logical action @grantshapps @BorisJohnson
‘The Highway Code currently treats children walking to school and lorry drivers as if they are equally responsible for their own or other people's safety. These changes will redress that balance." bbc.co.uk/news/uk-58021450































